why choose us

First received: March 22, 2023

Clinical Trial: Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Head and Neck Cancer

Study Type: INTERVENTIONAL


Official Title: A Pilot Window of Opportunity Study of Imatinib in Combination With Cetuximab in Patients With Squamous Cell Carcinomas of the Head and Neck

Brief Summary: The goal of this clinical trial is to find if levels of a protein called AXL in tumor cells relate to how tumors respond to cetuximab (CTX) combined with imatinib in participants with head and neck cancer.This interventional study will occur in the time between diagnosis of your cancer and surgery to remove your tumor or radiation or chemoradiation treatment of your primary cancer.Participants will undergo a research blood draw and a research biopsy as part of the screening process, and will be in this research…

Read more